{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:01:39Z","timestamp":1792544499585,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaad.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T04:04:10Z","timestamp":1733025850000},"page":"S52-S63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S","title":["Pain management in hidradenitis suppurativa"],"prefix":"10.1016","volume":"91","author":[{"given":"Vedaja","family":"Surapaneni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina V.","family":"Milosavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-2854","authenticated-orcid":false,"given":"Lauren A.V.","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2340\/00015555-2815","article-title":"Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa","volume":"98","author":"Matusiak","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2024.09.006_bib2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamadermatol.2019.2610","article-title":"Incidence of long-term opioid use among opioid-naive patients with hidradenitis suppurativa in the United States","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/bjd\/ljac018","article-title":"Pain experiences among those living with hidradenitis suppurativa: a qualitative study","volume":"188","author":"Orenstein","year":"2023","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.19344","article-title":"Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa","volume":"184","author":"Kirby","year":"2021","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.09.006_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11916-017-0647-3","article-title":"Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa [corrected]","volume":"21","author":"Patel","year":"2017","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.006_bib8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1159\/000533740","article-title":"The influence of pain on reduced quality of life in patients with hidradenitis suppurativa: a single-center retrospective study","volume":"239","author":"Li","year":"2023","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: results from the global survey of impact and healthcare needs (VOICE) project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/bjd\/ljad215","article-title":"Healthcare experiences among patients with hidradenitis suppurativa: a qualitative study","volume":"189","author":"Sow","year":"2023","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jaad.2019.11.016","article-title":"Patients with hidradenitis suppurativa may suffer from neuropathic pain: a Finnish multicenter study","volume":"82","author":"Huilaja","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.09.006_bib13","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.3390\/jcm9124046","article-title":"Prevalence of neuropathic pain and related characteristics in hidradenitis suppurativa: a cross-sectional study","volume":"9","author":"Garcovich","year":"2020","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.jaad.2024.09.006_bib14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamadermatol.2023.3550","article-title":"Fibromyalgia in patients with hidradenitis suppurativa","volume":"159","author":"Aarts","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.09.006_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamadermatol.2021.2918","article-title":"Prevalence of central sensitization in patients with hidradenitis suppurativa","volume":"157","author":"Aarts","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.09.006_bib16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamadermatol.2023.3243","article-title":"Quantitative sensory testing to characterize sensory changes in hidradenitis suppurativa skin lesions","volume":"159","author":"Alsouhibani","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjd.18656","article-title":"Pain perception in patients with hidradenitis suppurativa","volume":"182","author":"Nielsen","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2020.09.039","article-title":"Pain management in hidradenitis suppurativa and a proposed treatment algorithm","volume":"85","author":"Savage","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.15233","article-title":"Hidradenitis suppurativa\/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group","volume":"33","author":"Zouboulis","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.006_bib24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaad.2018.05.015","article-title":"Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials","volume":"79","author":"Kimball","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of Anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2018.06.046","article-title":"Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial","volume":"80","author":"Vossen","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2024.09.006_bib27","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jid.2019.10.024","article-title":"A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain","volume":"140","author":"Gottlieb","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"10443","key":"10.1016\/j.jaad.2024.09.006_bib28","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jaad.2023.10.034","article-title":"Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study","volume":"90","author":"Kirby","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jamadermatol.2023.4800","article-title":"Efficacy and safety of the heat shock protein 90 inhibitor RGRN-305 in Hidradenitis Suppurativa: a parallel-design double-blind trial","volume":"160","author":"Ben Abdallah","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"10378","key":"10.1016\/j.jaad.2024.09.006_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/09546634.2020.1755008","article-title":"Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review","volume":"33","author":"Montero-Vilchez","year":"2022","journal-title":"J Dermatol Treat"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.006_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15439","article-title":"Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: a retrospective study","volume":"35","author":"Molinelli","year":"2022","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ced.14388","article-title":"Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation","volume":"46","author":"Caposiena Caro","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamadermatol.2023.6201","article-title":"Efficacy and durability of intravenous ertapenem therapy for recalcitrant Hidradenitis Suppurativa","volume":"160","author":"Nosrati","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2018.06.063","article-title":"Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa","volume":"80","author":"Golbari","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15068","article-title":"Ultrasound-guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: a prospective study","volume":"34","author":"Iannone","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib41","article-title":"Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa","volume":"10","author":"Salvador-Rodr\u00edguez","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.006_bib42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2016.06.049","article-title":"Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series","volume":"75","author":"Riis","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/DSS.0000000000002112","article-title":"Intralesional triamcinolone may not be beneficial for treating acute Hidradenitis Suppurativa Lesions: a double-blind, randomized, placebo-controlled trial","volume":"46","author":"Fajgenbaum","year":"2020","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/12034754231188319","article-title":"Efficacy and patient satisfaction associated with intramuscular triamcinolone therapy for acute flares of Hidradenitis Suppurativa","volume":"27","author":"Benesh","year":"2023","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaad.2020.04.092","article-title":"Efficacy of oral zinc and nicotinamide as maintenance therapy for mild\/moderate hidradenitis suppurativa: A controlled retrospective clinical study","volume":"83","author":"Molinelli","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.006_bib23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bjd.21821","article-title":"Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa","volume":"187","author":"Hasan","year":"2022","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamadermatol.2020.5857","article-title":"Expert knowledge, attitudes, and practices in management of Hidradenitis Suppurativa pain","volume":"157","author":"Jedrzejczak","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"issue":"2\u20133","key":"10.1016\/j.jaad.2024.09.006_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000477459","article-title":"Swiss practice recommendations for the management of Hidradenitis Suppurativa\/Acne inversa","volume":"233","author":"Hunger","year":"2017","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1203475417736290","article-title":"Hidradenitis Suppurativa: a novel model of care and an integrative strategy to adopt an orphan disease","volume":"22","author":"Gulliver","year":"2018","journal-title":"J Cutan Med Surg"},{"issue":"2 Suppl 1","key":"10.1016\/j.jaad.2024.09.006_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/abd1806-4841.20198607","article-title":"Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology","volume":"94","author":"Magalh\u00e3es","year":"2019","journal-title":"An Bras Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000536094","article-title":"Expert practices in Hidradenitis Suppurativa flare management: a cross-sectional survey study","volume":"10","author":"Masson","year":"2024","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib53","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jaad.2021.11.005","article-title":"Use of a punch biopsy tool as an alternative approach for incision and drainage of abscesses","volume":"86","author":"Blum","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2024.09.006_bib54","series-title":"Whaley & Wong\u2019s Nursing Care of Infants and Children","author":"Hockenberry","year":"1998"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.006_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/der2.122","article-title":"A practical, comprehensive guide to pain management hidradenitis suppurativa","volume":"3","author":"Li","year":"2022","journal-title":"Dermatol Rev"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib56","article-title":"Non-steroidal anti-inflammatory drugs for acute low back pain","volume":"4","author":"van der Gaag","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"9954","key":"10.1016\/j.jaad.2024.09.006_bib57","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(14)60805-9","article-title":"Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.006_bib58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5694\/mja2.50992","article-title":"The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews","volume":"214","author":"Abdel Shaheed","year":"2021","journal-title":"Med J Aust"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.006_bib59","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/annrheumdis-2016-210597","article-title":"Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis","volume":"76","author":"Machado","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2024.09.006_bib60","series-title":"Nelson Textbook of Pediatrics","author":"Robert","year":"2020"},{"key":"10.1016\/j.jaad.2024.09.006_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.jaad.2024.09.006_bib62","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJMra012626","article-title":"Analgesics for the treatment of pain in children","volume":"347","author":"Berde","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib63","article-title":"Non-steroidal anti-inflammatory drugs for chronic low back pain","volume":"2","author":"Enthoven","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"7365","key":"10.1016\/j.jaad.2024.09.006_bib64","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.325.7365.624","article-title":"Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs","volume":"325","author":"Mamdani","year":"2002","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.006_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"15","key":"10.1016\/j.jaad.2024.09.006_bib66","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib67","doi-asserted-by":"crossref","first-page":"27241","DOI":"10.52965\/001c.27241","article-title":"Buprenorphine for chronic pain: a safer alternative to traditional opioids","volume":"9","author":"Dalal","year":"2021","journal-title":"Health Psychol Res"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.006_bib68","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/pme.12386","article-title":"Sublingual Buprenorphine as an analgesic in chronic pain: a systematic review: Sublingual Buprenorphine for chronic pain","volume":"15","author":"Cote","year":"2014","journal-title":"Pain Med"},{"issue":"10","key":"10.1016\/j.jaad.2024.09.006_bib69","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1213\/00000539-199010000-00008","article-title":"Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia","volume":"71","author":"Abboud","year":"1990","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jemermed.2004.02.010","article-title":"Are one or two dangerous? Camphor exposure in toddlers","volume":"27","author":"Love","year":"2004","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1542\/peds.94.1.127","article-title":"Camphor revisited: focus on toxicity. Committee on Drugs. American Academy of Pediatrics","volume":"94","year":"1994","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib73","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0031-9384(94)90338-7","article-title":"Sensory irritation and coolness produced by menthol: evidence for selective desensitization of irritation","volume":"56","author":"Cliff","year":"1994","journal-title":"Physiol Behav"},{"issue":"9","key":"10.1016\/j.jaad.2024.09.006_bib74","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00520-015-2642-8","article-title":"Cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist","volume":"23","author":"Fallon","year":"2015","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib75","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaad.2007.04.008","article-title":"Menthol: a refreshing look at this ancient compound","volume":"57","author":"Patel","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6876","key":"10.1016\/j.jaad.2024.09.006_bib76","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature719","article-title":"Identification of a cold receptor reveals a general role for TRP channels in thermosensation","volume":"416","author":"McKemy","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00007632-199401001-00014","article-title":"Digital assessment of MRI for lumbar disc desiccation. A comparison of digital versus subjective assessments and digital intensity profiles versus discogram and macroanatomic findings","volume":"19","author":"Videman","year":"1994","journal-title":"Spine"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.006_bib78","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7326\/M16-2458","article-title":"Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline","volume":"166","author":"Chou","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib79","article-title":"Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews","volume":"5","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068182","article-title":"Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials","volume":"14","author":"Jeddi","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaad.2024.09.006_bib81","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaad.2024.09.006_bib83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jdin.2023.02.005","article-title":"Ambulatory palliative care among patients with hidradenitis suppurativa: a qualitative study","volume":"11","author":"Chu","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2024.09.006_bib84","doi-asserted-by":"crossref","unstructured":"Thompson LL, Chen ST, Lawton A, Charrow A. Palliative care in dermatology: A clinical primer, review of the literature. and needs assessment. J Am Acad Dermatol. 2021;85(3):708-717. https:\/\/doi.org\/10.1016\/j.jaad.2020.08.029","DOI":"10.1016\/j.jaad.2020.08.029"},{"issue":"12","key":"10.1016\/j.jaad.2024.09.006_bib92","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc12-0656","article-title":"Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life","volume":"35","author":"Boyle","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.006_bib93","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1756285609359317","article-title":"Treatment options in trigeminal neuralgia","volume":"3","author":"Obermann","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib95","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jocn.2007.04.010","article-title":"Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia","volume":"15","author":"Gomez-Arguelles","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"10","key":"10.1016\/j.jaad.2024.09.006_bib96","doi-asserted-by":"crossref","first-page":"78","DOI":"10.15844\/pedneurbriefs-18-10-7","article-title":"Risk-benefits of oxcarbazepine vs carbamazepine","volume":"18","author":"Millichap","year":"2004","journal-title":"Pediatr Neurol Briefs"},{"key":"10.1016\/j.jaad.2024.09.006_bib97","article-title":"Pregabalin and gabapentin for pain","volume":"369","author":"Mathieson","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2024.09.006_bib85","author":"Darnell"},{"issue":"5 Suppl 1","key":"10.1016\/j.jaad.2024.09.006_bib86","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jaad.2015.07.046","article-title":"Pain management in patients with hidradenitis suppurativa","volume":"73","author":"Horv\u00e1th","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.006_bib87","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2014.11.039","article-title":"Chronic pain management in dermatology: a guide to assessment and nonopioid pharmacotherapy","volume":"73","author":"Enamandram","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.006_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11916-021-00948-1","article-title":"CBT and CFT for Chronic Pain","volume":"25","author":"Hadley","year":"2021","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib89","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1037\/a0035623","article-title":"Acceptance and commitment therapy and mindfulness for chronic pain: model, process, and progress","volume":"69","author":"McCracken","year":"2014","journal-title":"Am Psychol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.006_bib90","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaad.2023.07.1037","article-title":"Wound care for patients with hidradenitis suppurativa: recommendations of an international panel of experts","volume":"89","author":"Chopra","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.006_bib91","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/M16-2579","article-title":"Yoga, physical therapy, or dducation for chronic low back pain: a randomized noninferiority trial","volume":"167","author":"Saper","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224028147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224028147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T02:11:08Z","timestamp":1733883068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224028147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0190962224028147"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.09.006","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain management in hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}